About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:
At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.
PMID: 35355174 Journal: JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS Year: 2022 Reference: J Autism Dev Disord. 2022 Mar 30. pii: 10.1007/s10803-022-05524-z. doi: 10.1007/s10803-022-05524-z. Impact factor: 4.291 Publication type: Review in international publication Authors: Setien-Ramos, Imanol, Lugo-Marin, Jorge, Gisbert-Gustemps, Laura, Diez-Villoria, Emiliano, Canal-Bedia, Ricardo, Ramos-Quiroga, Josep Antoni, Magan-Maganto, Maria et al. DOI: 10.1007/s10803-022-05524-z
PMID: 35325633 Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY Year: 2022 Reference: Eur Neuropsychopharmacol. 2022 May;58:86-98. doi: 10.1016/j.euroneuro.2022.02.009. Epub 2022 Mar 21. Impact factor: 4.6 Publication type: Review in international publication Authors: Calvo, Natalia, Garcia-Gonzalez, Sara, Perez-Galbarro, Citlalli, Regales-Peco, Christina, Lugo-Marin, Jorge, Ramos-Quiroga, Josep-Antoni, Ferrer, Marc et al. DOI: 10.1016/j.euroneuro.2022.02.009
PMID: 35324373 Journal: Journal of Dual Diagnosis Year: 2022 Reference: J Dual Diagn. 2022 Apr-Jun;18(2):71-80. doi: 10.1080/15504263.2022.2051110. Epub 2022 Mar 24. Impact factor: 1.613 Publication type: Paper in international publication Authors: Daigre, Constanza, Grau-Lopez, Lara, Palma-Alvarez, Raul F, Perea-Ortueta, Marta, Sorribes-Puertas, Marta, Serrano-Perez, Pedro, Quesada, Marta, Segura, Lidia, Coronado, Marta, Ramos-Quiroga, Josep Antoni et al. DOI: 10.1080/15504263.2022.2051110
PMID: 35231832 Journal: SCHIZOPHRENIA RESEARCH Year: 2022 Reference: Schizophr Res. 2022 May;243:32-42. doi: 10.1016/j.schres.2022.02.026. Epub 2022 Feb 26. Impact factor: 4.939 Publication type: Paper in international publication Authors: Parellada, Mara, Gonzalez-Pinto, Ana, Hidalgo-Figueroa, Maria, Bernardo, Miquel, Cuesta, Manuel J, Vazquez-Bourgon, Javier, Mas, Sergi, Contreras, Fernando, Bioque, Miquel, Mezquida, Gisela et al. DOI: 10.1016/j.schres.2022.02.026
PMID: 34313783 Journal: JOURNAL OF PEDIATRIC PSYCHOLOGY Year: 2021 Reference: J Pediatr Psychol. 2021 Aug 19;46(8):927-938. doi: 10.1093/jpepsy/jsab058. Impact factor: 3.191 Publication type: Paper in international publication Authors: Daigre, Constanza, Forner-Puntonet, Mireia, Castell-Panisello, Eudald, Quintero, Jesus, Ariceta, Gema, Gran, Ferran, Iglesias-Serrano, Ignacio, Gisbert-Gustemps, Laura, Espanol-Martin, Gemma, Parramon, Gemma et al. DOI: 10.1093/jpepsy/jsab058
PMID: 34238926 Journal: Translational Psychiatry Year: 2021 Reference: Transl Psychiatry. 2021 Jul 8;11(1):382. doi: 10.1038/s41398-021-01504-6. Impact factor: 6.222 Publication type: Paper in international publication Authors: Richarte, Vanesa, Sanchez-Mora, Cristina, Corrales, Montserrat, Fadeuilhe, Christian, Vilar-Ribo, Laura, Arribas, Lorena, Garcia, Estela, Rosales-Ortiz, Silvia Karina, Arias-Vasquez, Alejandro, Soler-Artigas, Maria et al. DOI: 10.1038/s41398-021-01504-6
PMID: 34234734 Journal: Frontiers in Neurology Year: 2021 Reference: Front Neurol. 2021 Jun 21;12:675520. doi: 10.3389/fneur.2021.675520. eCollection 2021. Impact factor: 4.003 Publication type: Paper in international publication Authors: Saposnik, Gustavo, Bueno-Gil, Guillermo, Sempere, Angel P, Rodriguez-Antiguedad, Alfredo, Del Rio, Beatriz, Baz, Mar, Terzaghi, Maria, Ballesteros, Javier, Maurino, Jorge et al. DOI: 10.3389/fneur.2021.675520
PMID: 34212338 Journal: Clinical & Translational Oncology Year: 2021 Reference: Clin Transl Oncol. 2021 Dec;23(12):2460-2473. doi: 10.1007/s12094-021-02654-1. Epub 2021 Jul 1. Impact factor: 3.405 Publication type: Paper in international publication Authors: Ruano, D, Rubio, P, Verges, R, Valverde, C, Gallego, S, Bernabeu, D, Hindi, N, Mata, C, Marquez, C, Orcajo, J et al. DOI: 10.1007/s12094-021-02654-1
The doctoral training program of excellence led by the UAB TOUCH MSCA-COFUND, focused on the field of mental health, opens its second call until March 31.
Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.
These results reinforce the need for more individualized attention to address educational needs from an early stage.
